- Home
- ARWR vs AVTR Comparison
ARWR vs AVTR Comparison
Compare ARWR & AVTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | AVTR |
|---|---|---|
| Founded | 2003 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 7.8B |
| IPO Year | 1993 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARWR | AVTR |
|---|---|---|
| Price | $67.81 | $12.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 15 |
| Target Price | ★ $73.70 | $14.53 |
| AVG Volume (30 Days) | 2.6M | ★ 9.2M |
| Earning Date | 02-05-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $829,448,000.00 | ★ $6,575,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23258.15 | N/A |
| 52 Week Low | $9.57 | $10.62 |
| 52 Week High | $76.76 | $23.32 |
Technical Indicators
Market Signals| Indicator | ARWR | AVTR |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 55.32 |
| Support Level | $61.65 | $11.74 |
| Resistance Level | $68.24 | $12.90 |
| Average True Range (ATR) | 3.79 | 0.46 |
| MACD | -0.69 | 0.01 |
| Stochastic Oscillator | 45.29 | 54.91 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About AVTR Avantor Inc.
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.